|
21. |
Epidemiology and Clinical Course of Liver Diseases: Identification of Candidates for Hepatic Transplantation |
|
Hepatology,
Volume 4,
Issue S1,
1984,
Page 84-94
John M. Vierling,
Preview
|
PDF (1276KB)
|
|
摘要:
AbstractAmong a variety of liver diseases that have been treated by hepatic transplantation, several were chosen for evaluation because of their frequency or high rate of fatality. Information regarding the incidence and prevalence in the United States, the natural history with conventional therapy, and prognostic indicators of a terminal phase is reviewed. Based on this information, specific candidates for hepatic transplantation are identified.
ISSN:0270-9139
DOI:10.1002/hep.1840040722
出版商:W.B. Saunders
年代:1984
数据来源: WILEY
|
22. |
Human Liver Transplantation: Analysis of Data on 540 Patients from Four Centers |
|
Hepatology,
Volume 4,
Issue S1,
1984,
Page 95-101
Bruce F. Scharschmidt,
Preview
|
PDF (611KB)
|
|
摘要:
AbstractThe results of liver transplantation in a total of 540 patients from four centers in the United States and Western Europe have been collated. Twenty‐five per cent of all transplants were performed for neoplastic disease. One– and 3–year survivals for this group were approximately 26 and 12% overall, and survival differed little for patients transplanted before and after January 1, 1980. Among the 44% of patients transplanted for endstage cirrhosis, 3–year survival was lowest for patients with alcoholic cirrhosis (20%). Three‐year survival was greater for patients with nonalcoholic cirrhosis (29% overall), did not differ markedly among the various subtypes, and was greater for patients transplanted after January 1, 1980 (42%), as compared with before (22%). Patients with biliary atresia, sclerosing cholangitis, and metabolic and miscellaneous disorders constituted the remaining 30% of patients; 3–year survival varied from about 20 to 44% overall for the various subgroups, with a consistent trend toward improved survival among patients transplanted after January 1, 1980. The use of cyclosporin may not wholly explain this improved survival among more recently transplanted patients. Quality of life for transplant recipients surviving at least 3 months, as judged by a limited amount of data regarding time‐in‐hospital and functional status, app
ISSN:0270-9139
DOI:10.1002/hep.1840040723
出版商:W.B. Saunders
年代:1984
数据来源: WILEY
|
23. |
Medical Treatment Vs. Transplantation in Liver Disorders |
|
Hepatology,
Volume 4,
Issue S1,
1984,
Page 102-106
Steven Schenker,
Preview
|
PDF (586KB)
|
|
ISSN:0270-9139
DOI:10.1002/hep.1840040724
出版商:W.B. Saunders
年代:1984
数据来源: WILEY
|
24. |
National Institutes of Health Consensus Development Conference Statement: Liver2 Transplantation‐June 20–23, 1983 |
|
Hepatology,
Volume 4,
Issue S1,
1984,
Page 107-110
Preview
|
PDF (469KB)
|
|
ISSN:0270-9139
DOI:10.1002/hep.1840040725
出版商:W.B. Saunders
年代:1984
数据来源: WILEY
|
25. |
Masthead |
|
Hepatology,
Volume 4,
Issue S1,
1984,
Page -
Preview
|
PDF (136KB)
|
|
ISSN:0270-9139
DOI:10.1002/hep.1840040701
出版商:W.B. Saunders
年代:1984
数据来源: WILEY
|
|